Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Short and long-term human trials for with GLP-1s for methamphetamine and cocaine should be a top priority
is supported by funds from the Ministry of Education and Science of Poland within the project 'Excellence Initiative - Research University', the Ministry of Health of Poland within the project 'Center of Artificial Intelligence in Medicine at the Medical University of Bialystok', the Medical Research Agency within the project 'Regional Center for Digital Medicine at the Medical University of Bialystok' (grant number 2023/ABM/02/00008), and the American Diabetes Association grant 11-22-PDFPM-03
Oral: SMD, 0.01
One fatal, serious adverse event, small cell lung carcinoma with dissemination, occurred in the 6 mg group but was deemed unrelated to trial participation
The Role of GLP-1 and GLP-1 Agonist in Type 2 Diabetes
